Celltrion to Conduct Trial of Remsima as COVID-19 Therapeutics in UK
Celltrion Healthcare announced on Wednesday that it would commence clinical trials of Remsima, an anti-inflammatory biosimilar, on COVID-19 patients this month ...
Tag: Celltrion Healthcare
FREE NEWSLETTER
Trending posts
- LG, Luxoft Join Hands to Officially Launch Automotive Solution Alluto
158 total views, 3 views today
- South Korea to Unveil Prototype of First Developed Fighter Jet KF-X
146 total views, 3 views today
- Hanwha to Strengthen Future Space Industry Growth With ‘Space Hub’
141 total views, 6 views today
- Naver Affiliate LINE Games Secures 100 Bln Won from China Firm Tencent
438 total views, 15 views today
- SK hynix Begins Mass-Producing Premium 18GB LPDDR5 mobile DRAM
126 total views, 2 views today
- Spotify Pulls Out K-Pop Music Provided by Kakao M
130 total views, 3 views today
- SK Partners with Plug Power to Expand Asia’s Green Hydrogen Economy
155 total views, 2 views today
- Kakao Diversifies E-Commerce Services with Zigzag Acquisition
51 total views, 5 views today
- KT Expands Quantum Cryptographic Communication and Information Tech
96 total views, 2 views today
- Korean Startup Real Water’s Unique Solution to Keep Microplastics at Bay
122 total views, 2 views today
Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |